Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
Alexander E Rock,1 Jeremy Lerner,2 Melissa E Badowski1 1University of Illinois, College of Pharmacy, Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, Chicago, IL 60612, USA; 2University of Illinois, College of Pharmacy, Department of Pharmacy Practice, Chicago, IL 606...
Guardado en:
Autores principales: | Rock AE, Lerner J, Badowski ME |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b786ca651b64a9ba953e2d36b977853 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
por: Fernandez C, et al.
Publicado: (2019) -
Impacto de la terapia anti retroviral en la mortalidad de pacientes VIH (+) chilenos: estudio caso-control (MORTAR)
por: Wolff R,Marcelo, et al.
Publicado: (2000) -
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Seth C. Inzaule, et al.
Publicado: (2018) -
Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
por: Matthew Weichseldorfer, et al.
Publicado: (2021) -
HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
por: Chanin Sillapachaiyaporn, et al.
Publicado: (2021)